We conducted a nutrition study that demonstrated safety and tolerability. This randomized, double-blinded, placebo controlled study took place across multiple sites in the United States. The study also showed statistically and clinically significant reductions in A1C level and blood sugar spikes in people with type 2 diabetes who are taking metformin. You can read more about the study here:
We are continuing with other studies, and we’ve set up a registry with the Mayo Clinic to collect independent data on the real world effects of our product.